Clinicopathological Correlation of Endometrial Thickness and Ovulatory Patterns in PCOS Women: A Systematic Review and Meta-analysis

Fakhria  Ijaz; Roomi  Memon; Seema Ashfaque  Abro; Tanzeel Shafique Ul  Rehman

doi:10.36283/ziun-pjmd14-3/065

Authors

Fakhria Ijaz Allama Iqbal Memorial Hospital, Gujranwala,Pakistan.
Roomi Memon Isra University, Hyderabad, Sindh, Pakistan
Seema Ashfaque Abro Liaquat University of Medical and Health Sciences, Jamshoro, Sindh, Pakistan
Tanzeel Shafique Ul Rehman King Abdul Aziz University, Jeddah, KSA

DOI:

https://doi.org/10.36283/ziun-pjmd14-3/065

Keywords:

Polycystic Ovary Syndrome, Endometrium, Menstruation Disturbances , Reproductive Health

Abstract

Background: Polycystic Ovary Syndrome (PCOS) is an endocrine condition that causes trouble with ovulation, increased male hormone levels, and ovaries filled with cysts. The aim of the systematic review and meta-analysis was to provide an evaluation of the effect of polycystic ovary syndrome (PCOS) on the endometrial thickness and histopathological abnormalities in women.

Methods: The present systematic review and meta-analysis have been performed following PRISMA 2020 recommendations. Up to May 2025, four databases were searched to capture the English-language studies. Research articles with observational, cross-sectional, or retrospective cohort design that compared PCOS to non-PCOS sub-groups were included in the trial. The Newcastle-Ottawa Scale was used in determining the risk of bias. Meta-analysis was performed using RevMan 5.4.1 software, using a random-effects model. The degree of heterogeneity was determined as I².

Results: Five studies that included 20,914 participants were included. Meta-analysis indicated an insignificant difference between the Endometrial thickness (EMT) of population groups measured (SMD: 0.28; 95 % CI: -0.29 to 0.85; p > 0.05) and high heterogeneity (I² = 88%). The pooled OR indicated a significantly elevated risk of endometrial hyperplasia or abnormal histology in women with menstrual irregularities (OR: 1.31; 95% CI: 1.09-1.57; p < 0.05). Subgroup and sensitivity confirmation effects were established.

Discussion: Although endometrial thickness alone does not seem to vary significantly, menstrual irregularities in PCOS are related to a higher prevalence of endometrial hyperplasia. A key limitation of this review is the small number of studies, limiting the generalizability of the findings. Further studies are required to validate the usefulness of histological evaluation in PCOS patients.

Author Biographies

Fakhria Ijaz, Allama Iqbal Memorial Hospital, Gujranwala,Pakistan.

Department of Obstetrics and Gynaecology,
Roomi Memon, Isra University, Hyderabad, Sindh, Pakistan

Department of Physiology,
Seema Ashfaque Abro, Liaquat University of Medical and Health Sciences, Jamshoro, Sindh, Pakistan

Department of Obstetrics and Gynaecology,
Tanzeel Shafique Ul Rehman, King Abdul Aziz University, Jeddah, KSA

Faculty of Medicine,

References

1. Shah B, Parnell L, Milla S, Kessler M, David R. Endometrial thickness, uterine, and ovarian ultrasonographic features in adolescents with polycystic ovarian syndrome. J Pediatr Adolesc Gynecol. 2010 Jun;23(3):146-152. doi:10.1016/j.jpag.2009.07.002.

2. Lynn AY, Solomon N, Zamani M, Rowe E, Seifer DB, Vash-Margita A. Evaluation of the association of endometrial thickness, insulin resistance, and menstrual patterns in adolescent females with polycystic ovarian syndrome. J Pediatr Adolesc Gynecol. 2023 Apr;36(2):134-139. doi:10.1016/j.jpag.2022.11.005.

3. Gaba A, Hörath S, Hager M, Marculescu R, Ott J. Basal anti-Müllerian hormone levels and endometrial thickness at midcycle can predict the outcome after clomiphene citrate stimulation in anovulatory women with PCOS: a retrospective study. Arch Gynecol Obstet. 2019 Dec;300(6):1751-1757. doi:10.1007/s00404-019-05359-7.

4. Palomba S, Piltonen TT, Giudice LC. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2021 Jun;27(3):584-618. doi:10.1093/humupd/dmaa051.

5. Huang J, Lin J, Xia L, Tian L, Xu D, Liu P, et al. Decreased endometrial thickness is associated with higher risk of neonatal complications in women with polycystic ovary syndrome. Front Endocrinol. 2021 Nov;12(1). doi:10.3389/fendo.2021.766601.

6. Dinsdale NL, Crespi BJ. Endometriosis and polycystic ovary syndrome are diametric disorders. Evol Appl. 2021 Jul;14(7):1693-1715. doi:10.1111/eva.13244.

7. Fujii S, Oguchi T. Shapes of the uterine cavity are different in women with polycystic ovary syndrome. Reprod Med Biol. 2023 Dec;22(1):12508. doi:10.1002/rmb2.12508.

8. Mahtab NT, Mahmud N, Chowdhury TA. Transvaginal sonographic assessment of follicular development and endometrial thickness in letrozole stimulated cycles of PCOS and non-PCOS infertile women. BIRDEM Med J. 2019 Sep;9(3):234-239. doi:10.3329/birdem.v9i3.43087.

9. Pathare ADS, Hinduja I, Mahadik RC. Basic aspects of endometrial receptivity in PCOS patients. Mol Biol Rep. 2022 Feb;49(2):1519-1528. doi:10.1007/s11033-021-06976-9.

10. Shalom-Paz E, Atia N, Atzmon Y, Hallak M, Shrim A. The effect of endometrial thickness and pattern on the success of frozen embryo transfer cycles and gestational age accuracy. Gynecol Endocrinol. 2021 May;37(5):428-432. doi:10.1080/09513590.2020.1821359.

11. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021 Mar;10(1):89. doi:10.1186/s13643-021-01626-4.

12. Guo Y, Yang J, Chen H, Zhou Y, Yang Y, Wang B, et al. Enhancing understanding of endometrial function in patients with PCOS: clinical and immunological insights. J Ovarian Res. 2025 Mar;18(1):52. doi:10.1186/s13048-025-01638-x.

13. Li X, Ji YF, Feng Y, Liu SW. Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators. Gynecol Endocrinol. 2024 Dec;40(1):2312895. doi:10.1080/09513590.2024.2312895.

14. Zeng X, Yang C. Correlation analysis of BMI with ovulation effect and clinical pregnancy rate in patients with polycystic ovary syndrome. Am J Transl Res. 2024 Aug;16(8):4174-4181. doi:10.62347/KYES1276.

15. Amooee S, Akbarzadeh-Jahromi M, Motavas M, Zarei F. Comparing endometrial hysteroscopic and histological findings of infertile women with polycystic ovary syndrome and unexplained infertility: a cross-sectional study. Int J Reprod Biomed. 2020 Jan;18(1):33-40. doi:10.18502/ijrm.v18i1.6195.

16. Al-Jefout M, Al-Qtaitat A, Al-Rahal D, Al-Nawaiseh N, Rawashdeh F. Endometrial thickness as a predictor of endometrial hyperplasia in infertile patients with polycystic ovary syndrome. Open J Obstet Gynecol. 2018 Feb;8(2):92-104. doi:10.4236/ojog.2018.82012.

17. Ghafari A, Maftoohi M, Eslami Samarin M, Barani S, Banimohammad M, Samie R. The last update on polycystic ovary syndrome (PCOS), diagnosis criteria, and novel treatment. Endocr Metab Immune Disord Drug Targets. 2025;17(1):100228. doi:10.1016/j.endmts.2025.100228.

18. Chang S, Dunaif A. Diagnosis of polycystic ovary syndrome: which criteria to use and when? Endocrinol Metab Clin North Am. 2021 Mar;50(1):11-23. doi:10.1016/j.ecl.2020.10.002.

19. Chen W, Pang Y. Metabolic syndrome and PCOS: pathogenesis and the role of metabolites. Metabolites. 2021 Dec;11(12):869. doi:10.3390/metabo11120869.

20. Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020 May;35:100937. doi:10.1016/j.molmet.2020.01.001.

21. Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, et al. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med. 2023 Feb;12(4):1454. doi:10.3390/jcm12041454.

22. Son JB, Jeong JE, Joo JK, Na YJ, Kim CW, Lee KS. Measurement of endometrial and uterine vascularity by transvaginal ultrasonography in predicting pregnancy outcome during frozen-thawed embryo transfer cycles. J Obstet Gynaecol Res. 2014 Jun;40(6):1661-1667. doi:10.1111/jog.12406.

23. Bai X, Zheng L, Li D, Zhang L, Chen C, Wang J, et al. Research progress of endometrial receptivity in patients with polycystic ovary syndrome: a systematic review. Reprod Biol Endocrinol. 2021;19:122. doi:10.1186/s12958-021-00802-4.

24. Wang L, Wei W, Cai M. A review of the risk factors associated with endometrial hyperplasia during perimenopause. Int J Womens Health. 2024 Sep;16:1475–1482. doi:10.2147/IJWH.S481509.

25. McCormick BA, Wilburn RD, Thomas MA, Williams DB, Maxwell R, Aubuchon M. Endometrial thickness predicts endometrial hyperplasia in patients with polycystic ovary syndrome. Fertil Steril. 2011 Jun;95(8):2625-2627. doi:10.1016/j.fertnstert.2011.04.022.

26. Pan Y, Feng L, Yang CX, Sun Y, Zhang CW, Zhang SM, et al. Correlation between different endometrial preparation protocols and pregnancy outcome of frozen embryo transfer in patients with polycystic ovary syndrome: a retrospective study. Gynecol Endocrinol. 2023 Dec;39(1):2217260. doi:10.1080/09513590.2023.2217260.

27. Oberg E, Gidlöf S, Jakson I, Mitsell M, Tollet Egnell P, Hirschberg AL. Improved menstrual function in obese women with polycystic ovary syndrome after behavioural modification intervention—a randomized controlled trial. Clin Endocrinol. 2019 Mar;90(3):468-478. doi:10.1111/cen.13919.

28. Baracat MCP, Baracat EC, Simões RS, Simões MJ, Maciel GAR, Azziz R, et al. Hormonal and metabolic factors influence the action of progesterone on the endometrium of women with polycystic ovary syndrome. Diagnostics. 2023 Jan;13(3):382. doi:10.3390/diagnostics13030382.

29. Hosseinzadeh P, Barsky M, Gibbons WE, Blesson CS. Polycystic ovary syndrome and the forgotten uterus. F&S Rev. 2021 Jan;2(1):11-20. doi:10.1016/j.xfnr.2020.12.001.

30. Eriksson G, Li C, Sparovec TG, Dekanski A, Torstensson S, Risal S, et al. Single-cell profiling of the human endometrium in polycystic ovary syndrome. Nat Med. 2025 Mar;31(3):1925–1938. doi:10.1038/s41591-025-03592-z.

31. Jia X, Yang L, Xu P, Li N, Chen C, Wang H. Endometrial cancer combined with polycystic ovary syndrome in 9 women under 40 years old: a case report. Biomed Rep. 2020 Nov;13(5):1-1. doi:10.3892/br.2020.1357.

32. Paulson M, Norstedt G, Sahlin L, Hirschberg AL. Association between prolactin receptor expression and proliferation in the endometrium of obese women with polycystic ovary syndrome. Gynecol Endocrinol. 2020 Mar;36(3):226-232. doi:10.1080/09513590.2019.1650343.

33. Farooq S, Memon FN, Khan FA, Naz U, Hira AK, Jabbar AA. Endometrial hyperplasia in polycystic ovarian syndrome patients having raised endometrial thickness. Ann Punjab Med Coll. 2020 Jun;14(2):183-186. doi:10.29054/apmc/2020.769.

34. Shahgheibi S, Seyedoshohadaei F, Khezri D, Ghasemi S. Endometrial and follicular development following stair-step and traditional protocols in women with polycystic ovary syndrome: an RCT. Int J Reprod Biomed. 2021 Jul;19(6):537-544. doi:10.18502/ijrm.v19i6.9375.

35. Collée J, Mawet M, Tebache L, Nisolle M, Brichant G. Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments. Gynecol Endocrinol. 2021 Oct;37(10):869-874. doi:10.1080/09513590.2021.1958310.

36. Hassan MG, Alnafa HM, Alsofyan N, Alsulimi RS, Alsllal S, Abaalkhail NA, et al. Ultrasonographic assessment of uterine measurements and endometrial thickness among healthy Saudi females sample. Int J Womens Health. 2025 Dec;17(1):67-73. doi:10.2147/IJWH.S487564.

37. Li X, Yang D, Pan P, Azziz R, Yang D, Cheng Y, et al. The degree of menstrual disturbance is associated with the severity of insulin resistance in PCOS. Front Endocrinol. 2022 Jun;13(1). doi:10.3389/fendo.2022.873726.

38. Ding H, Zhang J, Zhang F, Zhang S, Chen X, Liang W, et al. Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol. 2021;12:741764. doi:10.3389/fendo.2021.741764.

39. Yuan L, Wu H, Huang W, Bi Y, Qin A, Yang Y. The function of metformin in endometrial receptivity of patients with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2021;19(1):89. doi:10.1186/s12958-021-00772-7.

40. Zhao H, Zhang J, Cheng X, Li Y, Wang Y, Liu Y, et al. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 2023;16(1):9. doi:10.1186/s13048-022-01091-0.